Skip to main content

Table 1 Comparison of general information between the two groups

From: Clinical value of NT-proBNP, MPO, and NLR combined with echocardiography in prediction of malignant arrhythmia in elderly patients with valvular heart disease

Data

VHD group (n = 50)

Healthy control group (n = 55)

P

Age

62.20 ± 9.46

63.47 ± 10.08

0.504

Gender

  

0.706

 Male

30 (60.00)

31 (56.36)

 

 Female

20 (40.00)

24 (43.64)

 

BMI (kg/m2)

22.52 ± 1.46

22.16 ± 1.34

0.187

Hypertension

 

 Yes

9 (18.00)

  

 No

41 (82.00)

  

Diabetes

 Yes

13 (26.00)

  

 No

37 (74.00)

  

NYHA classification

  

 I-II

35 (70.00)

 

 III-IV

15 (30.00)

 
  1. VHD Valvular Heart Disease, BMI Body Mass Index, NYHA New York Heart Association